DICE Therapeutics; Lilly; Astellas; Pfizer; Agepha Pharma; AstraZeneca; Bavarian Nordic; Novo Nordisk

Today in FirstWord Pharma 's Industry News newsletter, we cover:

?? Lilly bets on IL-17 inhibitors with deal to buy DICE Therapeutics for $2.4 billion

? Pfizer's Talzenna gains FDA approval in prostate cancer, but only for those with HRR gene mutations

?? FDA okays Agepha's Lodoco to cut risk of cardiac events tied to heart disease

? AstraZeneca scraps GLP-1 programme AZD0186 in diabetes

?? Bavarian Nordic touts Phase III data for chikungunya virus jab in older adults

?? EU roll-out of Novo Nordisk's Wegovy stymied by demand across the pond

? much more

?? Get FirstWord's Industry News newsletter and stay ahead of the curve with the #pharma industry's top news and insights delivered to you??? https://firstwordpharma.com/register